| Article

JAMA reports a noted increase in opioid use disorder treatments in those enrolled in Medicaid. The study looked at over a million enrollees from 11 states: medication treatment prevalence in 2014 was 47.8% and in 2018, 57.1%. Of note, use of OUD medication was higher in pregnant women and white...

| Article

How much of a problem is doctor shopping? “Doctor shopping” is defined as ≥1 day of getting overlapping prescriptions for opioids from ≥2 prescribers and going to ≥3 pharmacies to have them filled. A recent article published in the Journal of Pain Research looked at patients with chronic noncancer...

| Article

The Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act was recently introduced into the House of Representatives, after working its way through the senate. Its goal? To make it easier to access non-opioid pain management treatments. The Act hopes to “address payment disincentives for...

| Article

Challenges. That’s what prescribers are facing when prescribing buprenorphine. They face barriers, hurdles, difficulties helping their patients overcome opioid use disorder. Even though things are changing—the federal government has removed some barriers, such as requiring special training for...

| Article

Does money talk? How can hospitals be encouraged to promote quicker treatment for opioid use disorder? Researchers at Perelman School of Medicine at the University of Pennsylvania published findings in the journal of Psychiatric Services, their objectives being, “a voluntary financial incentive...

| Article

An article in JAMA Network Open asked the question, “Have prescriptions for Schedule II opioids with high abuse potential, vs Schedule IV tramadol (lower abuse potential), decreased in the 18-month periods before and after publication of the Centers for Disease Control and Prevention opioid...

| Video

Dr. Martin Cheatle, Associate Professor at the University of Pennsylvania’s Perelman School of Medicine, offers his opinion on medications used to treat opioid use disorder: methadone, buprenorphine, and naltrexone.

| Article

As stated in the abstract of an article in JCO Clinical Cancer Informatics, a journal of the American Society of Clinical Oncology, “Approximately 40% of childhood cancer survivors experience chronic pain, with many also reporting pain-related disability. Given associations established in the...

| Article

A study reported in the journal Sleep posits that adolescents who experience sleep deficiency may develop into adults who misuse prescription opioids. The study, the self-reported National Longitudinal Study of Adolescent to Adult Health followed >12,000 participants over the course of 12 years...

| Article

The Journal of Rheumatology reports a concerning increase in hospitalizations for opioid use disorder (OUD) in patients with musculoskeletal conditions. Comparing data from 1998-2000 vs 2015-2016, OUD hospitalization rates for gout, osteoarthritis, fibromyalgia, rheumatoid arthritis, and low back...

Subscribe to opioid use disorder (OUD)

Sign-Up